Immatics Biotechnologies GmbH - Company Profile

Powered by

All the sales intelligence you need on Immatics Biotechnologies GmbH in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Immatics Biotechnologies GmbH fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Immatics Biotechnologies GmbH.

Back to companies

Immatics Biotechnologies GmbH: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Immatics Biotechnologies GmbH, a subsidiary of Immatics NV, operates in the pharmaceuticals and healthcare industry, specializing in oncology therapy area. It focuses on developing medications for the prevention and treatment of cancer. The company is headquartered in Germany.

 Gain a 360-degree view of Immatics Biotechnologies GmbH and make more informed decisions for your business Gain a 360-degree view of Immatics Biotechnologies GmbH and make more informed decisions for your business Learn more
Headquarters Germany
Address Paul-Ehrlich-Strasse 15, Tuebingen, Baden-Wurttemberg, 72076
Website www.immatics.com
Telephone 49 7071 53970
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Immatics Biotechnologies GmbH premium industry data and analytics

20+

Pipeline Drugs

Identify which of Immatics Biotechnologies GmbH’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

9

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Clinical Trials

Determine Immatics Biotechnologies GmbH go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Immatics Biotechnologies GmbH key executives to enhance your sales strategy Gain insight into Immatics Biotechnologies GmbH key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?